Page 7 - Alok Malik News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alok malik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alok Malik Today - Breaking & Trending Today

Omron: Glenmark, Omron join hands to create awareness on blood pressure monitoring

Through the campaign called “Take Charge @18” both the companies are aiming to reach out to around 92,000 healthcare professionals and around 10 crore Indians in one year. Glenmark has initiated discussions with 94 cardiologists acrossIndia, leading to a unanimous consensus that 18 is the ideal age to commence blood pressure screening. ....

Tetsuya Yamada , Glenmark Pharmaceuticals For The Take , Indian Council Of Medical Research , Alok Malik , India Business Head , Glenmark Pharmaceuticals , Take Charge , Indian Council , Medical Research , Journal Of The Association Physicians India , Blood Pressure Monitoring , Glenmark Pharma ,

Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Glenmark Pharmaceuticals Ltd on Thursday said it has slashed the price of breast cancer drug Trastuzumab by bringing its brand Trumab at Rs 15,749 for a 440 mg vial from Rs 54,000 earlier. ....

Alok Malik , Glenmark Pharmaceuticals Ltd On , Glenmark Pharmaceuticals Executive Vice , Glenmark Pharmaceuticals Ltd , Pharmaceuticals Executive Vice President , India Formulations ,

Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer HER2-positive, and the company markets its version in India under the brand name Trumab . ....

Glenmark Pharma , Alok Malik , Glenmark Pharmaceuticals Ltd On , Glenmark Pharmaceuticals Executive Vice , Pharmaceuticals Ltd , Pharmaceuticals Executive Vice President , India Formulations ,

Trastuzumab price: Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer HER2-positive, and the company markets its version in India under the brand name Trumab . It is now priced at Rs 15,749 for a 440 mg vial from Rs 54,000 earlier. ....

Alok Malik , Glenmark Pharmaceuticals Ltd On , Glenmark Pharmaceuticals Executive Vice , Pharmaceuticals Ltd , Pharmaceuticals Executive Vice President , India Formulations ,